An interventional study of Splint in Trigger Finger, sponsored by Waikato Hospital. Enrolling by invitation at 1 site in New Zealand. Per ClinicalTrials.gov, last updated 2026-09-16.
Sponsored by Waikato Hospital · Not applicable, Interventional, and Treatment
The purpose of this research is to evaluate the effectiveness of two splint designs in conservative management of trigger finger.
This study aims to analyse and compare the effectiveness of metacarpophalangeal joint blocking splint versus relative motion extension splint for trigger finger. This will help us find out which one of the two splint designs is more effective in the management of trigger finger, thus improving treatment outcomes for patients with trigger finger.
93 studies on the registry are indexed under Trigger Finger Disorder; 22 are open to participants now.
This study's planned enrollment of 30 is below the median of 66 across 75 interventional studies indexed under Trigger Finger Disorder.
Browse Trigger Finger Disorder studies →Waikato Hospital is the lead sponsor of 5 studies on the registry; 3 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Metacarpophalangeal joint blocking splint
Other: Splint
Relative motion extension splint
Other: Splint
Comparison of splints for trigger finger
Green's classification for trigger finger
Green's classification is an objective outcome measure. The therapist grades the triggering by observing the finger when the patient makes a full fist. Grade I: Pain/history of catching Grade II: Demonstrable catching but can actively extend digit Grade III: Demonstrable locking, requiring passive extension Grade IV: Fixed flexion contracture Lowest score is I; highest score is IV
Time frame: 12 weeks
QuickDASH (Disability of Arm, Shoulder and Hand)
The QuickDASH is a patient rated questionnaire that rates patient's ability to perform certain tasks as well as severity of symptoms. The best score is 0 (no difficulty) and the lowest score is 100 (severe difficulty).
Time frame: 12 weeks
Visual Analogue Scale (VAS)
The VAS is a patient rated outcome measure that enables the patient to rate the intensity of pain from 0 (no pain) to 10 (worse pain that can possibly be)
Time frame: 12 weeks
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Waikato Hospital